Bluefin Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-7,231
| Closed | -$842K | – | 692 |
|
|
2021
Q4 | $842K | Buy |
7,231
+231
| +3% | +$27.2K | 0.07% | 247 |
|
|
2021
Q3 | $841K | Sell |
7,000
-1,262
| -15% | -$147K | 0.1% | 179 |
|
|
2021
Q2 | $990K | Sell |
8,262
-688
| -8% | -$75.5K | 0.07% | 189 |
|
|
2021
Q1 | $890K | Buy |
+8,950
| New | +$900K | 0.05% | 209 |
|
|
2020
Q4 | – | Hold |
0
| – | -$510K | – | 707 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 181 |
|
|
2019
Q1 | – | Sell |
-4,450
| Closed | -$338K | – | 405 |
|
|
2018
Q4 | $338K | Sell |
4,450
-250
| -5% | -$19.5K | 0.04% | 196 |
|
|
2018
Q3 | $372K | Buy |
4,700
+1,350
| +40% | +$102K | 0.04% | 252 |
|
|
2018
Q2 | $235K | Buy |
3,350
+150
| +5% | +$10.8K | 0.02% | 274 |
|
|
2018
Q1 | $224K | Buy |
3,200
+50
| +2% | +$3.46K | 0.02% | 265 |
|
|
2017
Q4 | $219K | Hold |
3,150
| – | – | 0.02% | 341 |
|
|
2017
Q3 | $213K | Buy |
+3,150
| New | +$199K | 0.03% | 318 |
|
|
2017
Q1 | – | Sell |
-4,900
| Closed | -$268K | – | 478 |
|
|
2016
Q4 | $268K | Buy |
+4,900
| New | +$278K | 0.02% | 292 |
|
|
2016
Q3 | – | Sell |
-19,969
| Closed | -$1.21M | – | 444 |
|
|
2016
Q2 | $1.21M | Buy |
+19,969
| New | +$1.16M | 0.13% | 129 |
|
|
2015
Q1 | – | Sell |
-7,572
| Closed | -$533K | – | 430 |
|
|
2014
Q4 | $533K | Sell |
7,572
-433,561
| -98% | -$31M | 0.04% | 340 |
|
|
2014
Q3 | $31.5M | Buy |
441,133
+110,880
| +34% | +$8.12M | 2.02% | 6 |
|
|
2014
Q2 | $24.5M | Buy |
330,253
+323,508
| +4,796% | +$23.4M | 1.25% | 9 |
|
|
2014
Q1 | $400K | Buy |
+6,745
| New | +$436K | 0.03% | 340 |
|
Other funds holding AZN
